SEP 16, 2014
Seven ophthalmologists whose research led to the development of ranibizumab are among the recipients of the 2014 António Champalimaud Vision Award, the highest distinction in ophthalmology and visual science.
The award was given for the development of anti-angiogenic therapy for retinal disease. The researchers include Joan Whitten Miller, M.D., Evangelos S. Gragoudas, M.D., and Patricia A. D’Amore, Ph.D., MBA, of Massachusetts Eye and Ear; Lloyd Paul Aiello, M.D., Ph.D., of Mass. Eye and Ear and Joslin Diabetes Center; George L. King, M.D., of Joslin Diabetes Center; and Anthony P. Adamis, M.D., of Genentech, who is also affiliated with HMS Ophthalmology and Mass. Eye and Ear. Napoleone Ferrara, M.D., of University of California, San Diego School of Medicine and Moores Cancer Center, also received the award.
The 2014 António Champalimaud Vision Laureates were honored on Sept. 10, 2014 during a ceremony held at the Champalimaud Centre for the Unknown in Lisbon, Portugal. Presiding at the ceremony was His Excellency Aníbal António Cavaco Silva, President of the Portuguese Republic.